Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR4 | P61073 | 15/20 | 0.36 |
| ▸ | OPRL1 | P41146 | 4/20 | 0.31 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.31 |
| ▸ | DRD2 | P14416 | 1/20 | 0.31 |
| ▸ | DRD4 | P21917 | 1/20 | 0.31 |
| ▸ | DRD3 | P35462 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8306260 | 0.87 | CXCR4 (0.38) | CXCR4OPRL1KCNH2DRD2DRD4 | |
| SCHEMBL2476528 | 0.87 | CXCR4 (0.38) | CXCR4OPRL1KCNH2DRD2DRD4 | |
| SCHEMBL2472087 | 0.87 | CXCR4 (0.38) | CXCR4OPRL1KCNH2DRD2DRD4 | |
| SCHEMBL15387261 | 0.76 | CXCR4 (0.38) | CXCR4OPRL1DRD2DRD4DRD3 | |
| SCHEMBL2470062 | 0.76 | CXCR4 (0.38) | CXCR4OPRL1DRD2DRD4DRD3 | |
| SCHEMBL2474634 | 0.76 | CXCR4 (0.38) | CXCR4OPRL1DRD2DRD4DRD3 | |
| SCHEMBL2478196 | 0.76 | CXCR4 (0.43) | CXCR4OPRL1 | |
| SCHEMBL2474557 | 0.76 | CXCR4 (0.43) | CXCR4OPRL1 | |
| SCHEMBL30586955 | 0.76 | CXCR4 (0.43) | CXCR4OPRL1 | |
| SCHEMBL25634128 | 0.76 | CXCR4 (0.43) | CXCR4OPRL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2374804-A1 | Chemokine receptor binding heterocyclic compounds with enhanced efficacy | Genzyme Corporation (US) | 2011-10-12 | — | — | EP | claimed |